PrimeVax Immuno-Oncology

PrimeVax Immuno-Oncology

Biotechnology Research South San Francisco, California, United States 7 employees
Employees
7

PrimeVax Immuno-Oncology Overview

Headquarters
South San Francisco, California, United States
Website
primevax.com
Industry
Biotechnology Research
Employees
7
Founded
2015
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords

About PrimeVax Immuno-Oncology

PrimeVax Immuno-Oncology, Inc. is developing the only one-time, one-week cancer treatment. We use a combination of the dengue fever virus and autologous dendritic cells to induce a strong immune response along with personalized tumor targeting.

PrimeVax Immuno-Oncology Contact Details

People in AeroLeads
4

PrimeVax Immuno-Oncology Org Chart

Sample employees and titles
Name Title Contact
Jim Jordan Founder & CEO, White Cross Worldwide®
View
Bob Battista Board Member, Executive, Founder
View
Tony Chen Founder / President @ Primevax
View
Warren Williams Founder & Chief Technology Officer @
View

Employees by Management Level

Executive 4 profiles

Compare Similar Companies to PrimeVax Immuno-Oncology